Meeting Banner
Abstract #2990

Serine de novo synthesis in glioma patients studied through 13C isotopomer analysis

Kumar Pichumani1, Omkar B Ijare2, Robert M Bachoo3, and Elizabeth A Maher3
1Neurosurgery, Houston Methodist Research Institute, Houston, TX, United States, 2Houston Methodist Research Institute, Houston, TX, United States, 3UT Southwestern Medical Center, Dallas, TX, United States

Synopsis

Keywords: Radiomics, Metabolism, 13C NMR, 13C isotopomer analysis

Motivation: The TCGA database reveals that gliomas exhibit the presence of phosphoglycerate dehydrogenase (PHGDH), a crucial enzyme in the generation of serine through de novo biosynthesis.

Goal(s): Our objective was to measure the serine biosynthesis flux in glioma patients.

Approach: We used 13C-glucose intravenous infusion during the surgical resection and 13C isotopomer analysis to track serine biosynthesis in patients.

Results: We detected 19.2% ± 6.5% of serine biosynthetic flux relative to lactate production and the generation of glycine to produce one-carbon units in both low-grade gliomas and GBMs.

Impact: These results indicate that targeting serine de novo synthesis may be of therapeutic value. We are currently working on developing PHGDH knockdown cell line from a GBM patient to test the effects of serine synthesis on cellular viability.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords